Published in AIDS Patient Care STDS on March 06, 2015
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep (2011) 6.90
Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis (2009) 4.96
The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis (2013) 4.04
Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet (2003) 3.84
A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am J Prev Med (2011) 3.24
Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr (2012) 2.74
Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis (2013) 2.60
Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58
Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care (2005) 2.42
A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS (2010) 1.81
Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis (2014) 1.76
Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. J Clin Epidemiol (2005) 1.72
Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav (2011) 1.67
Interventions to improve retention in HIV primary care: a systematic review of U.S. studies. Curr HIV/AIDS Rep (2012) 1.67
Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS (2013) 1.49
Trends in diagnoses of HIV infection in the United States, 2002-2011. JAMA (2014) 1.47
Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS (2013) 1.43
Progress along the continuum of HIV care among blacks with diagnosed HIV- United States, 2010. MMWR Morb Mortal Wkly Rep (2014) 1.43
A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis (2012) 1.42
Predicting virologic failure in an HIV clinic. Clin Infect Dis (2010) 1.39
Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics. Clin Infect Dis (2014) 1.31
Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med (2011) 1.21
Behind the cascade: analyzing spatial patterns along the HIV care continuum. J Acquir Immune Defic Syndr (2013) 1.19
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score. AIDS (2007) 1.15
Linking and retaining HIV patients in care: the importance of provider attitudes and behaviors. AIDS Patient Care STDS (2013) 1.15
Predictive factors for loss to postpartum follow-up among low income HIV-infected women in Texas. AIDS Patient Care STDS (2014) 0.94
A comparison study of methods for measuring retention in HIV medical care. AIDS Behav (2013) 0.92
A systematic review of health service interventions to improve linkage with or retention in HIV care. AIDS Care (2013) 0.90
Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence. AIDS Patient Care STDS (2014) 0.86
African American race and HIV virological suppression: beyond disparities in clinic attendance. Am J Epidemiol (2014) 0.85
Practice-based evidence in public health: improving reach, relevance, and results. Annu Rev Public Health (2014) 0.84
Impact of the nurse-led case management program with retention in care on mortality among people with HIV-1 infection: a prospective cohort study. Int J Nurs Stud (2012) 0.83
Factors associated with utilization of HAART amongst hard-to-reach HIV-infected individuals in Atlanta, Georgia. J AIDS HIV Res (2011) 0.81
The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 0.81
From diagnosis to engagement in HIV care: assessment and predictors of linkage and retention in care among patients diagnosed by emergency department based testing in an urban public hospital. AIDS Patient Care STDS (2014) 0.78
Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis (2007) 3.36
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3. J Infect Dis (2005) 1.81
Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis (2009) 1.72
Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing procedures. Clin Infect Dis (2008) 1.72
Nomenclature and definitions for emergency department human immunodeficiency virus (HIV) testing: report from the 2007 conference of the National Emergency Department HIV Testing Consortium. Acad Emerg Med (2008) 1.62
Oxidant stress is increased during treatment of human immunodeficiency virus infection. Clin Infect Dis (2003) 1.20
Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV. AIDS Patient Care STDS (2008) 1.18
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clin Infect Dis (2006) 1.18
Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr (2015) 1.17
Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and women. AIDS Behav (2009) 1.12
Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis (2014) 1.06
Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs. AIDS Educ Prev (2009) 0.95
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma. Antimicrob Agents Chemother (2003) 0.94
CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy. AIDS (2016) 0.93
Establishment of a validated training programme on the Eyesi cataract simulator. A prospective randomized study. Acta Ophthalmol (2014) 0.89
Tenofovir (TDF)-selected or abacavir (ABC)-selected low-frequency HIV type 1 subpopulations during failure with persistent viremia as detected by ultradeep pyrosequencing. AIDS Res Hum Retroviruses (2010) 0.86
Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care (2012) 0.85
Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons. J Acquir Immune Defic Syndr (2005) 0.80
Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network. J Acquir Immune Defic Syndr (2016) 0.79
Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy. J Acquir Immune Defic Syndr (2003) 0.79
Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens. J Acquir Immune Defic Syndr (2017) 0.75